Geneith Pharma marks 25yrs of transforming healthcare, disease control in Nigeria

By Chioma Obinna

As Nigeria continues to grapple with high disease burdens and challenges in access to essential medicines, Geneith Pharmaceuticals Limited, a leading indigenous pharmaceutical company, is marking 25 years of sustained contribution to public health.
The milestone is billed to be held next week in Lagos.
Since its founding in 2000, Geneith Pharmaceuticals has played a pivotal role in supplying affordable, life-saving medicines to millions of Nigerians.
The company has been particularly instrumental in malaria control, delivering globally compliant artemisinin-based combination therapies, while steadily expanding its portfolio to include other essential medicines.
Chairman of Geneith Pharmaceuticals, Chief Emmanuel Umenwa, said: “The challenges in Nigeria’s healthcare sector are significant, from ensuring medicine availability to supporting preventive public-health initiatives.
“For 25 years, Geneith has been committed to bridging these gaps, reinforcing local pharmaceutical capacity, and ensuring that no Nigerian is denied access to safe and effective medicines.”
The company has not only focused on pharmaceutical production but also on public-health interventions. Youth-led programs and community outreach initiatives have raised awareness about disease prevention, strengthened local health literacy, and promoted early access to treatment—critical factors in a country where out-of-pocket healthcare spending remains high.
With Nigeria pushing for medicine security and self-sufficiency, Geneith Pharmaceuticals is investing in expanded local manufacturing facilities. The initiative aligns with federal efforts to reduce dependence on imported drugs, enhance regulatory compliance, and strengthen the nation’s pharmaceutical supply chain.
“The goal is clear: improve medicine availability, reduce disease burden, and contribute to sustainable healthcare outcomes,” Umenwa said. “Our 25-year journey demonstrates that strategic partnerships, innovation, and investment in local capacity can produce lasting impact on national health.”
The silver-jubilee event will convene government officials, regulators, development partners, healthcare providers, and industry leaders to showcase the company’s achievements. Highlights will include corporate retrospectives, product exhibitions, recognition of strategic partners, and the unveiling of Geneith’s roadmap for continued growth and public-health sustainability.
Analysts say the company’s approach offers a model for addressing persistent healthcare challenges in Nigeria. By combining local production, adherence to international quality standards, and community engagement, Geneith has strengthened the pharmaceutical value chain while supporting disease control efforts nationwide.
As Nigeria faces ongoing threats from malaria, infectious diseases, and limited access to essential medicines, the company’s milestone underscores the importance of private-sector leadership in public health. Geneith Pharmaceuticals’ 25-year journey reflects both a commitment to addressing current healthcare gaps and a vision for a healthier, more resilient Nigeria in the decades ahead.

The post Geneith Pharma marks 25yrs of transforming healthcare, disease control in Nigeria appeared first on Vanguard News.